Comparison of Endogenous TP53 Genomic Status with Clonogenicity and Different Modes of Cell Death after X Irradiation

Radiation Research

Volumn 161, Issue 1, 2004, Pages 39-47

  Lu Hesselmann, Juxian ^a   Abend, Michael ^a   Van Beuningen, Dirk ^a  

^a Sanitatsakademie der Bundeswehr   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL TYPE; CLONOGENESIS; CLONOGENIC ASSAY; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOME; HUMAN; HUMAN CELL; METABOLISM; METHODOLOGY; MICRONUCLEUS TEST; MUTATION; NEOPLASM; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION RESPONSE; RADIOSENSITIVITY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; X IRRADIATION; X RAY;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE EXPRESSION REGULATION; HUMANS; MICRONUCLEUS TESTS; MUTATION; NEOPLASMS; ORGAN SPECIFICITY; RADIATION DOSAGE; RADIATION TOLERANCE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

RODENTIA;

EID: 0346103785     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3092     Document Type: Article

References (51)

1. C. Sarkar, A. Rathore, P. Chattopadhyaya, A. K. Mahapatra and S. Sinha, Role of 17p13.3 chromosomal region in determining p53 protein immunopositivity in human astrocytic tumors. Pathology 32, 84-88 (2000).
2. E. W. Newcomb, W. J. Madonia, S. Pisharody, F. F. Lang, M. Koslow and D. C. Miller, A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol. 3, 229-235 (1993).
3. P. Hainaut, T. Soussi, B. Shomer, M. Hollstein, M. Greenblatt, E. Hovig, C. C. Harris and R. Montesano, Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects. Nucleic Acids Res. 25, 151-157 (1997).
4. P. Hainaut and M. Hollstein, p53 and human cancer: The first ten thousand mutations. Adv. Cancer Res. 77, 81-137 (2000).
5. A. J. Levine, M. E. Perry, A. Chang, A. Silver, D. Dittmer, M. Wu and D. Welsh, The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer 69, 409-416 (1994).
6. T. Soussi, Y. Legros, R. Lubin, K. Ory and B. Schlichtholz, Multifactorial analysis of p53 alteration in human cancer: A review. Int. J. Cancer 57, 1-9 (1994).
7. L. Meng, L. Lin, H. Zhang, M. Nassiri, A. R. Morales and M. Nadji, Multiple mutations of the p53 gene in human mammary carcinoma. Mutat. Res. DNA Repair 435, 263-269 (1999).
8. M. Nadji, L. Meng, L. Lin, M. Nassiri and A. R. Morales, Detection of p53 gene abnormality by sequence analysis of archival paraffin tissue. A comparison with fresh-frozen specimens. Diagn. Mol. Pathol. 5, 279-283 (1996).
9. R. M. Elledge, Assessing p53 status in breast cancer prognosis: Where should you put the thermometer if you think your p53 is sick? J. Natl. Cancer Inst. 88, 141-143 (1996).
10. J. B. Little, Induction of genetic instability by ionizing radiation. C. R. Acad. Sci. Ser. III Vie 322, 127-134 (1999).
11. J. M. Lee and A. Bernstein, p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746 (1993).
12. P. M. O'Connor, J. Jackman, D. Jondle, K. Bhatia, I. Magrath and K. W. Kohn, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53, 4776-4780 (1993).
13. D. S. Biard, M. Martin, Y. L. Rhun, A. Duthu, J. L. Lefaix, E. May and P. May, Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res. 54, 3361-3364 (1994).
14. A. J. McIlwrath, P. A. Vasey, G. M. Ross and R. Brown, Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res. 54, 3718-3722 (1994).
15. F. Xia, X. Wang, Y. H. Wang, N. M. Tsang, D. W. Yandell, K. T. Kelsey and H. L. Liber, Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res. 55, 12-15 (1995).
16. J. C. Ribeiro, A. R. Barnetson, R. J. Fisher, H. Mameghan and P. J. Russell, Relationship between radiation response and p53 status in human bladder cancer cells. Int. J. Radiat. Biol. 72, 11-20 (1997).
17. K. Kawashima, K. Mihara, H. Usuki, N. Shimizu and M. Namba, Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int. J. Cancer 61, 76-79 (1995).
18. M. L. Smith, I. T. Chen, Q. Zhan, P. M. O'Connor and A. J. Fornace, Jr., Involvement of the p53 tumor suppressor in repair of UV-type DNA damage. Oncogene 10, 1053-1059 (1995).
19. D. G. Brachman, M. Beckett, D. Graves, D. Haraf, E. Vokes and R. R. Weichselbaum, p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 53, 3667-3669 (1993).
20. W. J. Slichenmyer, W. G. Nelson, R. J. Slebos and M. B. Kastan, Loss of a p53-associated G, checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53, 4164-4168 (1993).
21. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
22. Q. Zhan, I. Bae, M. B. Kastan and A. J. Fornace, Jr., The p53-dependent gamma-ray response of GADD45. Cancer Res. 54, 2755-2760 (1994).
23. A. R. Clarke, S. Gledhill, M. L. Hooper. C. C. Bird and A. H. Wyllie, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene 9, 1767-1773 (1994).
24. H. Symonds, L. Krall, L. Remington, M. Saenz Robles, S. Lowe, T. Jacks and T. van Dyke, p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711 (1994).
25. M. Abend, K. Kehe, M. Riedel and D. van Beuningen, Correlation of micronucleus and apoptosis assays with reproductive cell death can be improved by considering other modes of death. Int. J. Radiat. Biol. 76, 249-259 (2000).
26. E. J. Hall, Radiobiology for the Radiologist, 5th ed., pp. 32-50. Lippincott Williams & Wilkins, Philadelphia, 2000.
27. U. G. Hennig, N. L. Rudd and D. I. Hoar, Kinetochore immunofluorescence in micronuclei: A rapid method for the in situ detection of aneuploidy and chromosome breakage in human fibroblasts. Mutat. Res. 203, 405-414 (1988).
28. K. H. Falkvoll, The occurrence of apoptosis, abnormal mitoses, cells dying in mitosis and micronuclei in a human melanoma xenograft exposed to single dose irradiation. Strahlenther. Onkol. 166, 487-492 (1990).
29. L. C. Stephens, N. R. Hunter, K. K. Ang, L. Milas and R. E. Meyn, Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res. 135, 75-80 (1993).
30. D. Wolf and V. Rotter, Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA 82, 790-794 (1985).
31. I. C. Hsu, R. A. Metcalf, T. Sun, J. A. Welsh, N. J. Wang and C. C. Harris, Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428 (1991).
32. A. R. Clarke, C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper and A. H. Wyllie, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
33. W. S. El-Deiry, The p53 pathway and cancer therapy. Cancer J. 11, 229-236 (1998).
34. D. Calistri, F. Barzanti, M. DalSusino, R. Fedriga, L. Saragoni, L. Bernardi, L. Ricotti and W. Zoli, Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies. J. Biol. Regulat. Homeost. Agent 14, 120-127 (2000).
35. P. H. McKee, C. Hobbs and P. A. Hall, Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 23, 377-379 (1993).
36. S. H. Friend, R. Iggo, C. Ishioka, M. Fitzgerald, I. Hoover, E. O'Neill and T. Frebourg, Overcoming complexities in genetic screening for cancer susceptibility. Cold Spring Harbor Symp. Quant. Biol. 59, 673-676 (1994).
37. A. C. Souici, J. Mirkovitch, P. Hausel, L. K. Keefer and E. Felley Bosco, Transition mutation in codon 248 of the p53 tumor suppressor gene induced by reactive oxygen species and a nitric oxide-releasing compound. Carcinogenesis 21, 281-287 (2000).
38. B. Bressac, M. Kew, J. Wands and M. Ozturk, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429-431 (1991).
39. B. A. Rupnow and S. J. Knox, The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. Apoptosis 4, 115-143 (1999).
40. D. E. MacCallum, T. R. Hupp, C. A. Midgley, D. Stuart, S. J. Campbell, A. Harper, F. S. Walsh, E. G. Wright, A. Balmain and P. A. Hall, The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13, 2575-2587 (1996).
41. X. W. Wang, W. Vermeulen, J. D. Coursen, M. Gibson, S. E. Lupold, K. Forrester, G. Xu, L. Elmore, H. Yeh and C. C. Harris, The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev. 10, 1219-1232 (1996).
42. K. K. Walker and A. J. Levine, Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93, 15335-15340 (1996).
43. C. Venot, M. Maratrat, C. Dureuil, E. Conseiller, L. Bracco and L. Debussche, The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17, 4668-4679 (1998).
44. T. Soussi, C. Caron de Fromentel and P. May, Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5, 945-952 (1990).
45. T. Soussi and P. May, Structural aspects of the p53 protein in relation to gene evolution: A second look. J. Mol. Biol. 260, 623-637 (1996).
46. W. S. El-Deiry, S. E. Kern, J. A. Pietenpol, K. W. Kinzler and B. Vogelstein, Definition of a consensus binding site for p53. Nat. Genet. 1, 45-49 (1992).
47. A. B. Krepinski and J. A. Heddle, Micronuclei as a rapid and inexpensive measure of radiation-induced chromosomal aberrations. In Radiation-Induced Chromosome Damage in Man (T Ishihara and M. S. Sasaki, Eds.), pp. 93-109. Alan R. Liss, New York, 1983.
48. G. C. Jagefia, Frequency of micronucleated cells in the mouse bone marrow after exposure to various doses of gamma-radiation. Mutat. Res. 230, 45-48 (1990).
49. E. Siles, M. Villalobos, M. T. Valenzuela, M. I. Nunez, A. Gordon, T J. McMillan, V. Pedraza and J. M. Ruiz de Almodovar, Relationship between p53 status and radiosensitivity in human tumour cell lines. Br. J. Cancer 73, 581-588 (1996).
50. A. Cabelguenne, H. Blons, I. de Waziers, E. Carnot, A. M. Houllier, T Soussi, D. Brasnu, P. Beaune, O. Laccourreye and P. Laurent Puig, p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: A prospective series. J. Clin. Oncol. 18, 1465-1473 (2000).
51. N. Zaffaroni, E. Benini, D. Gornati, A. Bearzatto and R. Silvestrini, Lack of a correlation between p53 protein expression and radiation response in human tumor primary cultures. Stem Cells 13, 77-85 (1995).